|
Volumn 38, Issue 1, 2006, Pages 74-77
|
Economic evaluation of sirolimus-based immunosuppressive regimens in kidney graft recipients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
RAPAMYCIN;
STEROID;
TSUKUBAENOLIDE;
ACUTE GRAFT REJECTION;
ADULT;
AGED;
CALCULATION;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
FEMALE;
GRAFT RECIPIENT;
GRAFT SURVIVAL;
HEALTH CARE COST;
HOSPITAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MALE;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
SENSITIVITY ANALYSIS;
STATISTICAL SIGNIFICANCE;
SURGICAL PATIENT;
SURVIVAL;
TREATMENT DURATION;
ADULT;
AGED;
COST OF ILLNESS;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY TESTING;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
POLAND;
RETROSPECTIVE STUDIES;
SIROLIMUS;
SURVIVAL ANALYSIS;
TISSUE DONORS;
|
EID: 33644535149
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.11.092 Document Type: Conference Paper |
Times cited : (6)
|
References (5)
|